MIROSLAVA PAVLOVA: Open Payments
NPI 1659503928 · BURKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,196 in 51 payments from 16 companies in 2025. Trend: 2023 $494 · 2024 $805 · 2025 $1,196
Food & beverage: $1,196
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $208 |
| Madrigal Pharmaceuticals | 5 | $137 |
| Ardelyx, Inc. | 7 | $137 |
| ABBVIE INC. | 5 | $112 |
| Ipsen Biopharmaceuticals, Inc | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| QOL Medical, LLC | 3 | $63 |
| Janssen Biotech, Inc. | 2 | $57 |
| PFIZER INC. | 2 | $55 |
| GENZYME CORPORATION | 2 | $53 |
Products named: REZDIFFRA, IBSRELA, IQIRVO, DUPIXENT, RINVOQ, ENTYVIO, Sucraid, TREMFYA.
Industry payments across VA — which companies pay providers there.
